Intensive Growth Kit

RAD-140 SAFETY DATA SHEET
YK-11 SAFETY DATA SHEET
MK-677 SAFETY DATA SHEET

The Intensive Growth Kit is a three-compound combination designed for advanced preclinical investigation of hypertrophic signalling beyond conventional anabolic limits. It pairs a high-potency SARM with a myostatin-modulating steroidal SARM and a long-acting growth hormone secretagogue, forming a research framework that engages androgen receptor activation, follistatin upregulation, and sustained IGF-1 signalling within a single experimental design.

The mechanistic rationale lies in the inclusion of YK-11, a compound with distinctive activity at the intersection of AR modulation and myostatin pathway suppression. RAD-140 supplies tissue-selective AR agonism, MK-677 contributes elevated GH and IGF-1 levels, and YK-11 modulates follistatin expression to attenuate myostatin-mediated growth inhibition. Together they form a multi-axis hypertrophy model in which conventional AR signalling is supplemented by suppression of negative regulatory pathways.

Included in this kit:

• 1 × RAD-140 | 100 pellets, 10 mg active compound per pellet
• 1 × YK-11 | 100 pellets, 10 mg active compound per pellet
• 1 × MK-677 | 100 pellets, 10 mg active compound per pellet

Total: 300 pellets / 3,000 mg active compound.

Compound roles in this bundle:

RAD-140 (Testolone) – high-potency non-steroidal SARM providing tissue-selective AR agonism, with reduced off-target activity in prostate and dermal tissues.

YK-11 – steroidal SARM and myostatin modulator contributing the follistatin upregulation axis, with documented hypertrophic activity exceeding that of conventional non-steroidal SARMs in in vitro models.

MK-677 (Ibutamoren) – ghrelin receptor agonist supplying the somatotropic component through sustained GH and IGF-1 elevation.

Combined research applications:

• Preclinical models of advanced hypertrophic signalling beyond AR-mediated limits
• Studies of follistatin and myostatin pathway modulation alongside AR stimulation
• Investigation of myogenic differentiation and hypertrophic activity in muscle precursor cell models
• Research into bone mineral density under combined AR and somatotropic stimulation
• Comparative analysis of three-pathway anabolic stimulation versus AR-only controls

This kit is positioned as an intensive multi-pathway anabolic combination featuring high-potency compounds with overlapping anabolic mechanisms. Due to YK-11’s potential for partial suppression of endogenous testosterone in research models, investigators should account for HPG-axis monitoring within the experimental design and consider appropriate post-cycle endocrine recovery protocols.

⚠ Important Note: This product is supplied strictly for laboratory research use only. It is not approved for human consumption or therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease.